154 related articles for article (PubMed ID: 31886169)
1. Prognostic Predicting Role of Contrast-Enhanced Computed Tomography for Locally Advanced Pancreatic Adenocarcinoma.
Cheng CS; Liu W; Zhou L; Tang W; Zhong A; Meng Z; Chen L; Chen Z
Biomed Res Int; 2019; 2019():1356264. PubMed ID: 31886169
[TBL] [Abstract][Full Text] [Related]
2. Preoperative prediction of disease-free survival in pancreatic ductal adenocarcinoma patients after R0 resection using contrast-enhanced CT and CA19-9.
Li D; Peng Q; Wang L; Cai W; Liang M; Liu S; Ma X; Zhao X
Eur Radiol; 2024 Jan; 34(1):509-524. PubMed ID: 37507611
[TBL] [Abstract][Full Text] [Related]
3. Nomogram to predict survival of patients with advanced and metastatic pancreatic Cancer.
Deng GC; Lv Y; Yan H; Sun DC; Qu TT; Pan YT; Han QL; Dai GH
BMC Cancer; 2021 Nov; 21(1):1227. PubMed ID: 34781928
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of carbohydrate antigen 19-9 in unresectable locally advanced pancreatic cancer treated with dose-escalated intensity modulated radiation therapy and concurrent full-dose gemcitabine: analysis of a prospective phase 1/2 dose escalation study.
Vainshtein JM; Schipper M; Zalupski MM; Lawrence TS; Abrams R; Francis IR; Khan G; Leslie W; Ben-Josef E
Int J Radiat Oncol Biol Phys; 2013 May; 86(1):96-101. PubMed ID: 23265573
[TBL] [Abstract][Full Text] [Related]
5. The value of serum chromogranin A as a predictor of tumor burden, therapeutic response, and nomogram-based survival in well-moderate nonfunctional pancreatic neuroendocrine tumors with liver metastases.
Han X; Zhang C; Tang M; Xu X; Liu L; Ji Y; Pan B; Lou W
Eur J Gastroenterol Hepatol; 2015 May; 27(5):527-35. PubMed ID: 25822862
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of serum CA19-9 in patients with advanced pancreatic cancer receiving gemcitabine based chemotherapy.
An X; Li YH; Lin XB; Wang FH; Feng F; Xu RH; Jiang WQ; He YJ
Ai Zheng; 2009 Mar; 28(3):286-91. PubMed ID: 19619444
[TBL] [Abstract][Full Text] [Related]
7. Prognostic stratification in patients with pancreatic ductal adenocarcinoma after curative resection based on preoperative pancreatic contrast-enhanced CT findings.
Li D; Wang L; Cai W; Liang M; Ma X; Zhao X
Eur J Radiol; 2022 Jun; 151():110313. PubMed ID: 35447500
[TBL] [Abstract][Full Text] [Related]
8. A preoperative nomogram predicts prognosis of up front resectable patients with pancreatic head cancer and suspected venous invasion.
Shen YN; Bai XL; Jin G; Zhang Q; Lu JH; Qin RY; Yu RS; Pan Y; Chen Y; Sun PW; Guo CX; Li X; Ma T; Li GG; Gao SL; Lou JY; Que RS; Lau WY; Liang TB
HPB (Oxford); 2018 Nov; 20(11):1034-1043. PubMed ID: 29929784
[TBL] [Abstract][Full Text] [Related]
9. Unresectable pancreatic ductal adenocarcinoma: Role of CT quantitative imaging biomarkers for predicting outcomes of patients treated with chemotherapy.
Cheng SH; Cheng YJ; Jin ZY; Xue HD
Eur J Radiol; 2019 Apr; 113():188-197. PubMed ID: 30927946
[TBL] [Abstract][Full Text] [Related]
10. Prognostic nomogram for patients with unresectable pancreatic cancer treated with gemcitabine plus nab-paclitaxel or FOLFIRINOX: A post-hoc analysis of a multicenter retrospective study in Japan (NAPOLEON study).
Shibuki T; Mizuta T; Shimokawa M; Koga F; Ueda Y; Nakazawa J; Komori A; Otsu S; Arima S; Fukahori M; Makiyama A; Taguchi H; Honda T; Mitsugi K; Nio K; Ide Y; Ureshino N; Shirakawa T; Otsuka T
BMC Cancer; 2022 Jan; 22(1):19. PubMed ID: 34980029
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Nomogram for Resected Pancreatic Adenocarcinoma: A TRIPOD-Compliant Retrospective Long-Term Survival Analysis.
Xu D; Zhang K; Li M; Neoptolemos JP; Wu J; Gao W; Wu P; Cai B; Yin J; Shi G; Lu Z; Jiang K; Miao Y
World J Surg; 2020 Apr; 44(4):1260-1269. PubMed ID: 31900571
[TBL] [Abstract][Full Text] [Related]
12. Utility of (18) F-FDG PET/CT and CECT in conjunction with serum CA 19-9 for detecting recurrent pancreatic adenocarcinoma.
Rayamajhi S; Balachandran A; Katz M; Reddy A; Rohren E; Bhosale P
Abdom Radiol (NY); 2018 Feb; 43(2):505-513. PubMed ID: 28900703
[TBL] [Abstract][Full Text] [Related]
13. Prognostic factors in patients with advanced pancreatic cancer treated with gemcitabine alone or gemcitabine plus cisplatin: retrospective analysis of a multicenter study.
Inal A; Kos FT; Algin E; Yildiz R; Berk V; Tugba Unek I; Colak D; Colak D; Kucukoner M; Tamer Elkiran E; Helvaci K; Geredeli C; Dane F; Balakan O; Ali Kaplan M; Gok Durnali A; Harputoglu H; Goksel G; Ozdemir N; Buyukberber S; Gumus M; Ozkan M; Benekli M; Isikdogan A;
J BUON; 2012; 17(1):102-5. PubMed ID: 22517701
[TBL] [Abstract][Full Text] [Related]
14. Tumor fibrosis correlates with the survival of patients with pancreatic adenocarcinoma and is predictable using clinicoradiological features.
Shi S; Luo Y; Wang M; Lin Z; Song M; Li Z; Peng Z; Feng ST
Eur Radiol; 2022 Sep; 32(9):6314-6326. PubMed ID: 35420301
[TBL] [Abstract][Full Text] [Related]
15. Overall Survival Prediction and Usefulness of Second-Line Chemotherapy in Advanced Pancreatic Adenocarcinoma.
Vienot A; Beinse G; Louvet C; de Mestier L; Meurisse A; Fein F; Heyd B; Cleau D; d'Engremont C; Dupont-Gossart AC; Lakkis Z; Tournigand C; Bouché O; Rousseau B; Neuzillet C; Bonnetain F; Borg C; Vernerey D
J Natl Cancer Inst; 2017 Oct; 109(10):. PubMed ID: 28383673
[TBL] [Abstract][Full Text] [Related]
16. Nomograms predict long-term survival for patients with periampullary adenocarcinoma after pancreatoduodenectomy.
He C; Mao Y; Wang J; Duan F; Lin X; Li S
BMC Cancer; 2018 Mar; 18(1):327. PubMed ID: 29580215
[TBL] [Abstract][Full Text] [Related]
17. Analysis of Clinical Predictive Factors Affecting the Outcome of Second-Line Chemotherapy for Gemcitabine-Refractory Advanced Pancreatic Cancer.
Lee JE; Lee HS; Chung MJ; Park JY; Park SW; Song SY; Bang S
Gut Liver; 2020 Jan; 14(1):135-143. PubMed ID: 30974927
[No Abstract] [Full Text] [Related]
18. A radiomics nomogram for the prediction of overall survival in patients with hepatocellular carcinoma after hepatectomy.
Liu Q; Li J; Liu F; Yang W; Ding J; Chen W; Wei Y; Li B; Zheng L
Cancer Imaging; 2020 Nov; 20(1):82. PubMed ID: 33198809
[TBL] [Abstract][Full Text] [Related]
19. Prognostic nomogram for nonresectable pancreatic cancer treated with gemcitabine-based chemotherapy.
Hamada T; Nakai Y; Yasunaga H; Isayama H; Matsui H; Takahara N; Sasaki T; Takagi K; Watanabe T; Yagioka H; Kogure H; Arizumi T; Yamamoto N; Ito Y; Hirano K; Tsujino T; Tada M; Koike K
Br J Cancer; 2014 Apr; 110(8):1943-9. PubMed ID: 24642625
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of CT attenuation and FDG uptake of adipose tissue in patients with pancreatic adenocarcinoma.
Lee JW; Lee SM; Chung YA
Clin Radiol; 2018 Dec; 73(12):1056.e1-1056.e10. PubMed ID: 30077337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
